Menzel Garry E

Director at ADAPY; President and CEO at TCR2 THERAPEUTICS INC.

Sold, on record
$145k
Dollars the filings state
Form 4 sales
5
Latest Jul 10, 2023
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale TCR2 THERAPEUTICS INC.Plan not stated
    Dec 2, 2022 2022

    Sold 8,408 shares at $1.39 ($12k)

    Menzel Garry E, President & CEO

    Sold 3.8% of holdings ($307k position)212,650 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale TCR2 THERAPEUTICS INC.Plan not stated
    Dec 6, 2022 +4 days

    Sold 23,416 shares at $1.36 ($32k)

    Menzel Garry E, President and CEO

    Sold 11% of holdings ($289k position)189,234 shares leftFiling

  3. 3 Form 4 sale TCR2 THERAPEUTICS INC.Plan not stated
    Dec 8, 2022 +2 days

    Sold 18,425 shares at $1.26 ($23k)

    Menzel Garry E, President and CEO

    Sold 9.7% of holdings ($239k position)170,809 shares leftFiling

  4. 4 Form 4 sale TCR2 THERAPEUTICS INC.Plan not stated
    Dec 13, 2022 +5 days

    Sold 31,938 shares at $1.10 ($35k)

    Menzel Garry E, President and CEO

    Sold 18.7% of holdings ($187k position)138,871 shares left1.7x usual sizeFiling

  5. 5 Form 4 sale ADAPYUnusual
    Jul 10, 2023 +209 days

    Sold 47,702 shares at $0.91 ($43k)

    Menzel Garry E, Director

    No 10b5-1 planSold 38.9% of holdings ($112k position)75,056 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Menzel Garry E
Source
Jul 10, 2023Jul 10, 2023ADAPYDirectorForm 4 sale47,702$43k38.9%UnusualSEC
Dec 13, 2022Dec 13, 2022TCR2 THERAPEUTICS INC.President and CEOForm 4 sale31,938$35k18.7%Plan not statedSEC
Dec 8, 2022Dec 9, 2022TCR2 THERAPEUTICS INC.President and CEOForm 4 sale18,425$23k9.7%Plan not statedSEC
Dec 6, 2022Dec 7, 2022TCR2 THERAPEUTICS INC.President and CEOForm 4 sale23,416$32k11.0%Plan not statedSEC
Dec 2, 2022Dec 5, 2022TCR2 THERAPEUTICS INC.President & CEOForm 4 sale8,408$12k3.8%Plan not statedSEC